Probe Name	A-DA					Probe Info
Probe concentration	5 uM
Criteria	Quantification: Probe vs (Probe+Competitor)
Quantitative Method	SILAC
Competitor Name	Rofecoxib					Competitor Info
Competitor Concentration	25 uM
In Vivo Experiment Model	Model Type			Living cell
	Derived Tissue			Lung
	Disease Model		Lung adenocarcinoma [ICD-11:2C25]
	Model Name		Human lung adenocarcinoma cells (A-549)

Target ID	Target Name					Binding Ratio
LDTP08979	Prostaglandin reductase 2 (PTGR2)					12.0
LDTP03736	Prostaglandin G/H synthase 2 (PTGS2)					3.6
LDTP02359	Heme oxygenase 1 (HMOX1)					2.5
LDTP04183	Lanosterol synthase (LSS)					2.3
LDTP03976	Aldo-keto reductase family 1 member C3 (AKR1C3)					2.2
LDTP01763	Cytochrome b5 (CYB5A)					2.2
LDTP07003	Presequence protease, mitochondrial (PITRM1)					2.1

Target ID	Target Name					Binding Ratio
LDTP02016	Glucocorticoid receptor (NR3C1)					2.6

Target ID	Target Name					Binding Ratio
LDTP02354	Annexin A4 (ANXA4)					2.1

1	A Global Map of Lipid-Binding Proteins and Their Ligandability in Cells. Cell. 2015 Jun 18;161(7):1668-80. doi: 10.1016/j.cell.2015.05.045.